Farmed Italy

Bisferr ++

Dietary supplement

Description
Food supplement in buccal sachets with enteric release based on FERNANO , an innovative raw material consisting of ultramicronized microencapsulated bisglycinate iron.
The product contains 30 mg of Iron in each sachet. Iron contributes to normal cognitive function, normal energy metabolism, normal formation of red blood cells and hemoglobin, normal oxygen transport in the body, abnormal function of the immune system, reduction of tiredness and fatigue, it also intervenes in the process of cell division.

Bisferr ++, thanks to the sophisticated FERNANO technology, contains micro-complexes of ultramicronized bisglycinate iron that allow the release of Iron only in the intestinal tract, ensuring:

- high absorption and intestinal bioavailability of iron, an advantage obtained by reducing the size of the microencapsulated by means of the ULTRAMICRO technology;

- greater digestibility and excellent tolerability. Benefit guaranteed by the microencapsulation process which, through a polymeric coating membrane, protects the iron and avoids gastrointestinal problems, eliminates the aftertaste and metallic odor.

Ingrediants
FERNANO (microencapsulated ultramicronized bisglycinate iron); sweeteners: mannitol, sucralose; acidifier: citric acid; aroma; anti-caking agent: silicon dioxide.

Nutritional characteristics
214

* VNR = Nutritional Reference Value.

How to use
We recommend taking 1 sachet a day directly into the mouth.

Warnings
Supplements are not intended as a substitute for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended daily dose. Keep out of the reach of children under 3 years of age.
Excessive consumption can have laxative effects.

storage
Keep in a cold and dry place.

Format
14 sachets of 1.5 g.
Net weight: 21 g.

Cod. 942142074

Bibliography:
Iron monograph. Pdr tor Nutrional supplement, First Edition. Thomson POR Staff. 2001.pp 235-240. Iron monograph. POR Nutritional Supplements. New edition. s. Hendler, or. Jorvik. 2010. pp 247-253. Opinion of the Scientific Committee / Scientific Panel. Ironand contribution to the normal function of the immune system: evaluation of a healthclaim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2016; 14 (7): 4548 [8 pp]. M. Auerbach, H. Ballard, JR Trout, M. Mcllwain, A. Ackerman. H. Bahrain, et al. lntravenous Iron optimizes the Response to Recombinant Human Erythropoietin inCancer Patients With hemotherapy-Related Anemia: A Multicenter. Open-Label. RandomizedTrial. J Clin Oncol. 2004; 22 (7): 1301-7. s. Samman. Iron. Nutrition & Oletetics 2007; 64 (Suppl. 4): S126- S130. JL Spivak, P. Gasc6n, H. Ludwig. Anemia Management InOncology And Hematology. The Oncologist 2009; 14 (Suppl. 1): 43-56 www.theoncologist.com.